INFARMED publishes guidance clarifying the regulatory framework for digital health solutions including software, mobile applications and AI-based solutions as medical devices.
Portugal INFARMED · PortugalNew European regulations updating medical device rules enter into force on 19 July 2026.
Portugal INFARMED · PortugalINFARMED publishes initial FAQ clarifying changes to Portugal's National Health Technology Assessment System (SiNATS) introduced by Decree-Law 118/2026.
Portugal INFARMED · PortugalJoint informative circular on the mandatory use of legally valid medical prescriptions for dispensing prescription medicines.
Portugal INFARMED · PortugalList of homogeneous groups and unit reference prices for Q4 2026 approved and effective 1 October 2026.
Portugal INFARMED · PortugalThe list of homogeneous groups and unit reference prices for Q3 2026 under Portugal's reference pricing system has been updated.
Portugal INFARMED · PortugalLists annexed to the Regulation on prior notification of medicine transactions outside Portugal have been updated and enter into force the next business day after publication.
Portugal INFARMED · PortugalIn vitro laboratory testing for sunscreen sun protection factor is reliable and more ethical than human volunteer testing involving UV-induced sunburn.
Portugal INFARMED · PortugalEMA publishes guidance and template for Shortage Prevention Plans required of marketing authorisation holders for prescription medicines.
Portugal INFARMED · PortugalPortugal's INFARMED adds new homogeneous groups to the reference pricing system for the third quarter of 2026.
Portugal INFARMED · PortugalA study by INFARMED and EMA experts analyzes the evolution of medicinal product clinical trials in the EU/EEA between 2013 and 2025 using CTIS and EudraCT data.
Portugal INFARMED · PortugalInfarmed established a structured collaboration network with academic institutions to advance research in medicines, medical devices, and health technology assessment.
Portugal INFARMED · PortugalO Infarmed acolheu esta sexta-feira, 16 de outubro, a iniciativa "20 Anos do Estatuto do Medicamento - Memória, Evolução e Futuro", promovida pela Associação Portuguesa de Jovens Farmacêuticos (APJF), com o apoio inst...
Portugal INFARMED · PortugalA Diretora Executiva da Agência Europeia de Medicamentos (EMA), Emer Cooke, encontra-se em Portugal para uma visita oficial de três dias que inclui encontros com o Infarmed e representantes do setor da saúde, e a part...
Portugal INFARMED · PortugalPortugal's INFARMED announces the COMBINE programme has progressed to the second phase of its pilot project for coordinated evaluation of combined clinical trials.
Portugal INFARMED · PortugalCircular Informativa n.º 094/CD/100.20.200 de 15/10/2026
Portugal INFARMED · PortugalSubscreverSubscrever Notícias O Infarmed disponibiliza indicadores relativos aomês de agosto, destacando algumas atividades que contribuem para garantir aos cidadãos a qualidade, segurança e eficácia dos medicamentos ...
Portugal INFARMED · PortugalInfarmed runs a digital literacy campaign from September to 22 September on safe and informed purchase of condoms as medical devices.
Portugal INFARMED · PortugalEstamos a reforçar a nossa equipa da Unidade de Inspeção e procuramos profissionais que queiram abraçar um novo desafio. Quem procuramos?Candidatos que detenham um vínculo de emprego público previamente constituído e ...
Portugal INFARMED · PortugalSubscreverSubscrever Notícias Queremos reforçar a nossa equipa e estamos à procura de pessoas para a função de Assistente de Laboratório, que desejem fazer parte dela. Para mais informação sobre este e outros concurso...
Portugal INFARMED · PortugalO Infarmed disponibiliza indicadores relativos aomês de julho, destacando algumas atividades que contribuem para garantir aos cidadãos a qualidade, segurança e eficácia dos medicamentos e produtos de saúde, bem como a...
Portugal INFARMED · PortugalData : 21/08/2026
Portugal INFARMED · PortugalVolume 30, issues 5 and 6 (May and June 2026) of the Pharmacovigilance Bulletin is now available.
Portugal INFARMED · PortugalCircular Informativa n.º 081/CD/100.20.200 de 30/07/2026
Portugal INFARMED · PortugalO Conselho Diretivo do Infarmed reuniu esta segunda-feira com os diretores, assessores e restante equipa alargada de gestão da instituição, num encontro de trabalho dedicado ao balanço da atividade e ao alinhamento da...
Portugal INFARMED · PortugalPortugal has authorised the first clinical trial under the European FAST-EU pilot project.
Portugal INFARMED · PortugalINFARMED approved public funding for Sarclisa (isatuximab).
Portugal INFARMED · PortugalAbrysvo vaccine approved for public reimbursement in Portugal for passive protection against RSV lower respiratory tract disease in infants from birth to 6 months following maternal immunisation during pregnancy.
Portugal INFARMED · PortugalArexvy vaccine approved for public reimbursement in Portugal for active immunisation against RSV lower respiratory tract disease in adults aged 60 and over.
Portugal INFARMED · PortugalPortugal's INFARMED has approved public funding for Rinvoq (upadacitinib) following completion of the funding assessment.
Portugal INFARMED · PortugalPortugal's INFARMED has approved public funding for Alyftrek (deutivacaftor + tezacaftor + vanzacaftor); assessment report now available.
Portugal INFARMED · PortugalPublic reimbursement approval granted for Kaftrio (ivacaftor/tezacaftor/elexacaftor) in Portugal; evaluation report available.
Portugal INFARMED · PortugalPortugal's INFARMED has granted a positive preliminary assessment for public funding of Alhemo (Concizumab).
Portugal INFARMED · PortugalINFARMED denied public reimbursement funding for Loargys (pegzilarginase); evaluation report available.
Portugal INFARMED · PortugalINFARMED has approved the public funding evaluation for Skyrizi (risancizumab); evaluation report now available.
Portugal INFARMED · PortugalPortugal's INFARMED has approved public funding for Elahere (mirvetuximab soravtansina); evaluation report now available.
Portugal INFARMED · PortugalPortugal's INFARMED denied public funding for Evkeeza (evinacumab) for homozygous familial hypercholesterolaemia in adults and adolescents aged 12+ with no therapeutic alternative.
Portugal INFARMED · PortugalVoraxaze (glucarpidase) approved for public funding in hospital use to reduce toxic plasma methotrexate concentration in adults and children aged ≥28 days.
Portugal INFARMED · PortugalPortugal INFARMED approved public reimbursement for Twilev (ramipril + nebivolol) combination medicine.
Portugal INFARMED · PortugalBoehringer Ingelheim Portugal discontinues Nolotil (metamizole magnesium 2000 mg/5 ml injectable) from 1 February 2027 for manufacturing reasons.
Portugal INFARMED · Portugal